ZELIRA THERAPEUTICS LIMITED

Press Releases Zelira Therapeutics Limited

Equities

ZLD

AU000000ZLD1

Market Closed - Australian S.E. Other stock markets 11:26:26 2024-05-02 pm EDT			5-day change	1st Jan Change
0.68 ^AUD	-5.56%		-3.55%	-24.44%

Apr. 15	Zelira Therapeutics Receives AU$919,000 Funding Under Australian Government’s R&D Tax Incentive Scheme	MT
Feb. 22	Zelira Therapeutics Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Zelira Therapeutics : June 2022 Quarterly Activities Report	22-07-28	PU
Zelira Therapeutics : Update - Consolidation/Split - ZLD	22-04-21	PU
Zelira Therapeutics : and Health House execute Scheme Implementation Deed	22-04-18	PU
Zelira Therapeutics : Update - Consolidation/Split - ZLD	22-04-12	PU
Zelira Therapeutics : Consolidation/Split - ZLD	22-03-13	PU
Zelira Therapeutics : Appendix 4D & FY22 Interim Financial Report	22-02-28	PU
Zelira Therapeutics : Application for quotation of securities - ZLD	22-02-28	PU
Zelira Therapeutics : to acquire Health House International Limited	22-02-23	PU
Zelira Therapeutics : Appendix 4D & FY22 Interim Financial Report	22-02-23	PU
Zelira Therapeutics : Notification of cessation of securities - ZLD	22-02-20	PU
Zelira Therapeutics : Change of Director's Interest Notice x 4	22-02-04	PU
Zelira Therapeutics : Application for quotation of securities - ZLD	22-02-03	PU
Zelira Therapeutics : December 2021 Quarterly Activities Report	22-01-30	PU
Zelira Therapeutics : Application for quotation of securities - ZLD	22-01-18	PU
Zelira Therapeutics : 2021 Annual General Meeting Presentation	22-01-12	PU
Zelira Therapeutics : Notification regarding unquoted securities - ZLD	21-11-17	PU
Zelda Therapeutics : Investor Presentation - Non-deal Roadshow	19-11-24	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer